Gen. Mgr., Precision Oncology
Thu, Feb 29, 2024
Feb 29
exercised or converted securities in EXAS
4,724 shares @ $0.00
Decreased holdings by -25.00%
Net across this filing: +20.50% (+2,401 shares)
Option Exercise
Sale tied to a same-time option exercise
EXASEXACT SCIENCES CORP
Health CareHealth Care Services